Description
LL-37 is a cationic amphipathic peptide derived from the human cathelicidin antimicrobial protein hCAP-18. It is widely studied in vitro for its role in innate immune defense, antimicrobial activity, wound repair, and inflammatory signaling pathways. As the only human cathelicidin identified to date, LL-37 is of significant interest in laboratory models examining host defense peptides, bacterial resistance, and immunomodulation. This vial contains 5mg of lyophilized LL-37 peptide, optimized for controlled laboratory experimentation.
Reviews
There are no reviews yet.